Risultati della ricerca - Adil Daud

Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade–resistant melanoma: Final analysis from a phase 1b st... Autoría: Mohammed M. Milhem, Yousef Zakharia, Diwakar Davar, Elizabeth I. Buchbinder, Theresa Medina, Adil Daud, Antoni Ribas, Bartosz Chmielowski, Jiaxin Niu, Geoffrey T. Gibney, Kim Margolin, Anthony J. Olszanski, Inderjit Mehmi, Takami Sato, Montaser Shaheen, Luping Zhao, Heather Kelley, Hong Liu, Sujatha Kumar, Dmitri Bobilev, Arthur M. Krieg, James E. Wooldridge, John M. Kirkwood